FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input
This article was originally published in The Tan Sheet
Executive Summary
FDA expects to accomplish the goals of its Safe Use Initiative through a combination of voluntary moves by industry and regulatory activities
You may also be interested in...
FDA Warns Oversized, Unmarked Droppers Could Lead To Vitamin D Overdose
FDA recommends firms limit the size of droppers accompanying liquid vitamin D supplements for infants to the maximum recommended daily amount to reduce the risk of overdose
Drug Industry Avoids FDA's "Blunt Tools" With Safe Use Initiative Progress
Efforts by firms and other pharmaceutical industry stakeholders to drive FDA's Safe Use Initiative agenda lower the likelihood of the agency intervening with enforcement action, according to Principal Deputy Commissioner Josh Sharfstein
Firms Must Pair Education With Mechanical Constraints To Reduce Overdoses
Manufacturers must "engineer" safety constraints into acetaminophen products to reduce the risk of overdose and liver damage because consumer education alone is not enough, a joint FDA advisory committee said June 30